Literature DB >> 20399150

The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism.

Na Zhang1, Zhenxing Fu, Sarah Linke, Johana Chicher, Jeffrey J Gorman, DeeAnn Visk, Gabriel G Haddad, Lorenz Poellinger, Daniel J Peet, Frank Powell, Randall S Johnson.   

Abstract

Factor inhibiting HIF-1alpha (FIH) is an asparaginyl hydroxylase. Hydroxylation of HIF-alpha proteins by FIH blocks association of HIFs with the transcriptional coactivators CBP/p300, thus inhibiting transcriptional activation. We have created mice with a null mutation in the FIH gene and found that it has little or no discernable role in mice in altering classical aspects of HIF function, e.g., angiogenesis, erythropoiesis, or development. Rather, it is an essential regulator of metabolism: mice lacking FIH exhibit reduced body weight, elevated metabolic rate, hyperventilation, and improved glucose and lipid homeostasis and are resistant to high-fat-diet-induced weight gain and hepatic steatosis. Neuron-specific loss of FIH phenocopied some of the major metabolic phenotypes of the global null animals: those mice have reduced body weight, increased metabolic rate, and enhanced insulin sensitivity and are also protected against high-fat-diet-induced weight gain. These results demonstrate that FIH acts to a significant degree through the nervous system to regulate metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399150      PMCID: PMC2893150          DOI: 10.1016/j.cmet.2010.03.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  38 in total

1.  Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia.

Authors:  Ying-Jie Peng; Guoxiang Yuan; Deviprasadh Ramakrishnan; Suresh D Sharma; Marta Bosch-Marce; Ganesh K Kumar; Gregg L Semenza; Nanduri R Prabhakar
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

2.  Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.

Authors:  Erinn B Rankin; Mangatt P Biju; Qingdu Liu; Travis L Unger; Jennifer Rha; Randall S Johnson; M Celeste Simon; Brian Keith; Volker H Haase
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

3.  Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.

Authors:  Xiaofeng Zheng; Sarah Linke; José M Dias; Xiaowei Zheng; Katarina Gradin; Tristan P Wallis; Brett R Hamilton; Maria Gustafsson; Jorge L Ruas; Sarah Wilkins; Rebecca L Bilton; Kerstin Brismar; Murray L Whitelaw; Teresa Pereira; Jeffrey J Gorman; Johan Ericson; Daniel J Peet; Urban Lendahl; Lorenz Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

Review 4.  Hypoxia-inducible factor 1 (HIF-1) pathway.

Authors:  Gregg L Semenza
Journal:  Sci STKE       Date:  2007-10-09

Review 5.  Therapeutic manipulation of the HIF hydroxylases.

Authors:  Simon Nagel; Nick P Talbot; Jasmin Mecinović; Thomas G Smith; Alastair M Buchan; Christopher J Schofield
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

6.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Reto A Schuepbach; Erinn Rankin; Sophie Vaulont; Volker H Haase; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.

Authors:  James E Ferguson; Yaxu Wu; Kevin Smith; Peter Charles; Kyle Powers; Hong Wang; Cam Patterson
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

8.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

9.  Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor.

Authors:  Mathew L Coleman; Michael A McDonough; Kirsty S Hewitson; Charlotte Coles; Jasmin Mecinovic; Mariola Edelmann; Kristina M Cook; Matthew E Cockman; David E Lancaster; Benedikt M Kessler; Neil J Oldham; Peter J Ratcliffe; Christopher J Schofield
Journal:  J Biol Chem       Date:  2007-06-15       Impact factor: 5.157

10.  Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism.

Authors:  Julián Aragonés; Martin Schneider; Katie Van Geyte; Peter Fraisl; Tom Dresselaers; Massimiliano Mazzone; Ruud Dirkx; Serena Zacchigna; Hélène Lemieux; Nam Ho Jeoung; Diether Lambrechts; Tammie Bishop; Peggy Lafuste; Antonio Diez-Juan; Sarah K Harten; Pieter Van Noten; Katrien De Bock; Carsten Willam; Marc Tjwa; Alexandra Grosfeld; Rachel Navet; Lieve Moons; Thierry Vandendriessche; Christophe Deroose; Bhathiya Wijeyekoon; Johan Nuyts; Benedicte Jordan; Robert Silasi-Mansat; Florea Lupu; Mieke Dewerchin; Chris Pugh; Phil Salmon; Luc Mortelmans; Bernard Gallez; Frans Gorus; Johan Buyse; Francis Sluse; Robert A Harris; Erich Gnaiger; Peter Hespel; Paul Van Hecke; Frans Schuit; Paul Van Veldhoven; Peter Ratcliffe; Myriam Baes; Patrick Maxwell; Peter Carmeliet
Journal:  Nat Genet       Date:  2008-01-06       Impact factor: 38.330

View more
  106 in total

1.  Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates.

Authors:  Sarah E Wilkins; Sarah Karttunen; Rachel J Hampton-Smith; Iain Murchland; Anne Chapman-Smith; Daniel J Peet
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  MicroRNA-455 regulates brown adipogenesis via a novel HIF1an-AMPK-PGC1α signaling network.

Authors:  Hongbin Zhang; Meiping Guan; Kristy L Townsend; Tian Lian Huang; Ding An; Xu Yan; Ruidan Xue; Tim J Schulz; Jonathon Winnay; Marcelo Mori; Michael F Hirshman; Karsten Kristiansen; John S Tsang; Andrew P White; Aaron M Cypess; Laurie J Goodyear; Yu-Hua Tseng
Journal:  EMBO Rep       Date:  2015-08-24       Impact factor: 8.807

3.  Hypoxia Restrains Lipid Utilization via Protein Kinase A and Adipose Triglyceride Lipase Downregulation through Hypoxia-Inducible Factor.

Authors:  Ji Seul Han; Jung Hyun Lee; Jinuk Kong; Yul Ji; Jiwon Kim; Sung Sik Choe; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

4.  MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.

Authors:  Han Peng; Robert B Hamanaka; Julia Katsnelson; Liang-Liang Hao; Wending Yang; Navdeep S Chandel; Robert M Lavker
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

Review 5.  The role of HIF proteins in maintaining the metabolic health of the intervertebral disc.

Authors:  Elizabeth S Silagi; Ernestina Schipani; Irving M Shapiro; Makarand V Risbud
Journal:  Nat Rev Rheumatol       Date:  2021-06-03       Impact factor: 20.543

Review 6.  Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia.

Authors:  Sergiu-Bogdan Catrina
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

7.  Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.

Authors:  Lei Dong; Shuo You; Qing Zhang; Satoru Osuka; Narra S Devi; Stefan Kaluz; Jalisa H Ferguson; Hua Yang; Guoliang Chen; Binghe Wang; Hans E Grossniklaus; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2018-12-18       Impact factor: 12.531

Review 8.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

Review 9.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 10.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.